Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Nov 24, 2020

Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now...


Nov 24, 2020

Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now...


Mar 31, 2020

Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital.  The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...


Mar 31, 2020

Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital.  The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...


Mar 24, 2020

Dr. Hartmut Ehrlich, CEO, Abivax  gives an update of the French biotech's phase-2b clinical trial drug candidate ABX464 which has shown impressive results.  Dr. Ehrlich discusses how this revolutionary small molecule for oral administration has shown strong anti-inflammatory effects to solve the unmet needs of patients...